BioLargo, Inc.
BLGO
$0.16
$0.00-1.82%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.95M | -6.48M | -1.19M | -1.16M | -1.01M |
| Total Depreciation and Amortization | 137.00K | 103.00K | 81.00K | 85.00K | 67.00K |
| Total Amortization of Deferred Charges | 90.00K | 39.00K | 39.00K | 28.00K | -- |
| Total Other Non-Cash Items | 48.00K | 3.91M | -16.00K | -65.00K | 217.00K |
| Change in Net Operating Assets | 1.09M | -333.00K | -1.03M | -723.00K | -1.19M |
| Cash from Operations | -1.59M | -2.76M | -2.12M | -1.83M | -1.92M |
| Capital Expenditure | -13.00K | -33.00K | -- | -- | 25.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 289.00K | 192.00K | -- | -82.00K |
| Cash from Investing | -13.00K | 256.00K | 192.00K | -- | -57.00K |
| Total Debt Issued | -26.00K | 0.00 | 721.00K | 590.00K | 864.00K |
| Total Debt Repaid | 18.00K | -9.00K | -5.00K | -4.00K | -2.00K |
| Issuance of Common Stock | 960.00K | 1.43M | 2.10M | 295.00K | 730.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 2.15M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 15.00K | -15.00K | -- |
| Cash from Financing | 952.00K | 3.57M | 2.83M | 866.00K | 1.59M |
| Foreign Exchange rate Adjustments | -12.00K | 8.00K | 0.00 | -20.00K | 47.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -663.00K | 1.08M | 907.00K | -984.00K | -334.00K |